Glenmark Pharma gains 15% on launch of Favipiravir, a potential Covid drug

The company launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 at a price of about Rs 103 per tablet.

The company launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 at a price of about Rs 103 per tablet. https://ift.tt/2zVp6w4 June 21, 2020 at 06:12PM

Comments

Popular posts from this blog

US may impose tariffs on India, Italy for taxing internet firms like Google

No locus standi: India rejects US global religious freedom report